cIMPACT ‐ NOW update 11: Proposal on adaptation of diagnostic criteria for IDH ‐ and H3 ‐wildtype diffuse high‐grade gliomas and for posterior fossa ependymal tumors
Brain Pathology · 2026-01 · 36 (1)
DOI: 10.1111/bpa.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, online erschienen am 31.08.2025. Verfasst von Pieter Wesseling und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Amsterdam University Medical Centers/VU University Medical Center, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Brain Neoplasms, Central Nervous System Neoplasms, Ependymoma, Glioma. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The Consortium to Inform Molecular and Practical Approaches to Central Nervous System Tumor Taxonomy (cIMPACT‐NOW) updates provide guidelines for the diagnosis of central nervous system (CNS) tumors and suggestions for future World Health Organization (WHO) classification. Following publication of the fifth edition WHO Classification of CNS Tumors (WHO CNS5) in 2021, the cIMPACT‐NOW working group “Clarification” reviewed WHO CNS5 and prioritized two topics for further elucidation: (a) distinction of Glioblastoma, IDH‐wildtype from Diffuse pediatric‐type high‐grade glioma, H3‐wildtype, and IDH‐wildtype and (b) clarification of subgroups of posterior fossa (PF) ependymal tumors. Recommendations regarding the IDH‐ and H3‐wildtype diffuse high‐grade gliomas include: (1) use caution assigning CNS WHO grade 4 (diagnosis of Glioblastoma, IDH‐wildtype ) to a “ TERT promoter only”, histologically low‐grade, IDH‐wildtype tumor; (2) EGFR gene amplification and +7/−10 chromosome copy number alterations should not be used as solitary defining features for diagnosing high‐grade gliomas as Glioblastoma, IDH‐wildtype in patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Amsterdam University Medical Centers/VU University Medical Center, Amsterdam, the Netherlands.
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Humboldt-Universität and Freie Universität Berlin, Berlin, Germany.
- German Cancer Research Center, German Cancer Consortium, Partner Site Berlin, Heidelberg, Germany.
- Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Düsseldorf, Germany.
- German Cancer Consortium, Partner Site Essen/Düsseldorf, Düsseldorf, Germany.
ORCID-Profile: Pieter Wesseling, David Capper, Guido Reifenberger, Chitra Sarkar, Cynthia Hawkins, Arie Perry, Takashi Komori, Vani Santosh, Martin van den Bent, Michael Weller, Stefan M Pfister, Uri Tabori, Dominique Figarella-Branger, Brent A Orr, David N Louis
Zitieren
APA
Wesseling, P., Capper, D., Reifenberger, G., Sarkar, C., Hawkins, C., Perry, A., Kleinschmidt-DeMasters, B., Komori, T., Paulus, W., Santosh, V., van den Bent, M., Weller, M., Pfister, S. M., Tabori, U., Figarella-Branger, D., Orr, B. A., & Louis, D. N. (2026). cIMPACT ‐ NOW update 11: Proposal on adaptation of diagnostic criteria for IDH ‐ and H3 ‐wildtype diffuse high‐grade gliomas and for posterior fossa ependymal tumors. Brain Pathology, 36(1). https://doi.org/10.1111/bpa.70035
Vancouver
Wesseling P, Capper D, Reifenberger G, Sarkar C, Hawkins C, Perry A, et al. cIMPACT ‐ NOW update 11: Proposal on adaptation of diagnostic criteria for IDH ‐ and H3 ‐wildtype diffuse high‐grade gliomas and for posterior fossa ependymal tumors. Brain Pathology. 2026;36(1). doi:10.1111/bpa.70035
BibTeX
@article{Wesseling2026,
author = {Wesseling, Pieter and Capper, David and Reifenberger, Guido and Sarkar, Chitra and Hawkins, Cynthia and Perry, Arie and Kleinschmidt-DeMasters, Bette and Komori, Takashi and Paulus, Werner and Santosh, Vani and van den Bent, Martin and Weller, Michael and Pfister, Stefan M and Tabori, Uri and Figarella-Branger, Dominique and Orr, Brent A and Louis, David N},
title = {cIMPACT ‐ NOW update 11: Proposal on adaptation of diagnostic criteria for IDH ‐ and H3 ‐wildtype diffuse high‐grade gliomas and for posterior fossa ependymal tumors},
journal = {Brain Pathology},
year = {2026},
volume = {36},
number = {1},
doi = {10.1111/bpa.70035}
}
EUVIMED